Pathway profiling of a novel SRC inhibitor, AZD0424, in combination with MEK inhibitors for cancer treatment

A more comprehensive understanding of how cells respond to drug intervention, the likely immediate signalling responses and how resistance may develop within different microenvironments will help inform treatment regimes. The nonreceptor tyrosine kinase SRC regulates many cellular signalling process...

Descripción completa

Detalles Bibliográficos
Autores principales: Dawson, John C., Munro, Alison, Macleod, Kenneth, Muir, Morwenna, Timpson, Paul, Williams, Robert J., Frame, Margaret, Brunton, Valerie G., Carragher, Neil O.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8895456/
https://www.ncbi.nlm.nih.gov/pubmed/34856074
http://dx.doi.org/10.1002/1878-0261.13151

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8895456/
https://www.ncbi.nlm.nih.gov/pubmed/34856074
http://dx.doi.org/10.1002/1878-0261.13151

Ejemplares similares